Company name: ObjectiveHealth Inc., formerly known as ObjectiveGI
Amount raised: $6.99 million of a $10.99 million offering, according to a U.S. Securities and Exchange Commission filing
What they do: The Franklin-based company partners with physicians to integrate clinical trials into their practice, according to ObjectiveHealth’s website, with the goal of improving patient access to trials and proving pharmaceutical companies research opportunities.
Why it matters: ObjectiveHealth raised $6.6 million two years ago in a round led by Frist Cressey with participation from new and existing investors. At the time, the company, then known as ObjectiveGI, partnered with gastroenterology physicians to create clinical trial centers aimed at developing new therapies for NonAlcoholic SteatoHepatitis. The company, which then had 10 research clinics, planned to use the investment to double that number by the end of 2020.
It's not clear who ObjectiveHealth's investors are in the new round of funding.
What the funds will be used for: ObjectiveHealth could not be reached for comment.
